We connect your denied patients to a trusted telehealth partner for safe, affordable, physician-supervised GLP-1 access — plus an ongoing support community to keep them on their metabolic health journey. No extra work for your team.
When a GLP-1 is denied, most physicians don't have the bandwidth to fight it — and most patients don't know what to do next. The result: clinically appropriate care stalls, and patients fall through the cracks.
Practices complete an average of 39 prior authorizations per physician per week — consuming 13 hours of staff time. Less than 1 in 5 physicians always appeal a denial.
82% of physicians report patients abandon treatment after PA delays. For prescriptions costing $500+, the abandonment rate reaches 60%.
53% of patients report using weight-loss medications without consulting a physician — many acquiring them online or through social media.
We work alongside your care plan — never around it.
Fill out the form below, call, or email. We'll schedule a brief conversation to understand your practice, your patient volume, and how to build a compliant referral workflow together.
We introduce your patient to a trusted telehealth partner who provides physician-supervised GLP-1 access at an affordable cost — plus an ongoing community of support to help them stay motivated on their metabolic health journey.
Your patient gets safe, physician-overseen GLP-1 therapy and community support while remaining your patient. We reinforce your treatment plan and coordinate with your office as needed to maintain continuity of care.
After GLP-1 denials, my patients used to just disappear. Now I refer them to GLP After Denial and they come back engaged — they've got affordable access through a real physician and a community keeping them accountable. It's the missing piece we didn't have before.
Research shows that denied patients don't just wait — they either give up or go elsewhere.
Only 36% of GLP-1 patients remain on therapy at one year. Cost barriers and lack of navigation are the primary drivers of discontinuation.
More than half of patients using weight-loss medications report doing so without consulting a physician — acquiring them through pharmacies without prescriptions or online via social media.
Studies following patients who discontinue GLP-1 drugs consistently show most regain weight — erasing clinical progress and increasing long-term health risks.
Most denials go uncontested. 62% of physicians don't believe appeals will succeed, 48% say they lack time or staff to fight — yet when appealed, 80.7% of denials are overturned.
Your patients deserve a better option than abandonment or unregulated access. GLP After Denial bridges the gap.
Let's Build a Referral Pathway →Submit your contact information and we'll reach out to discuss how we can set up a safe, compliant referral pattern between your office and our team — tailored to your workflow.
Tell us about your practice and we'll be in touch within one business day.
Thank you, Doctor. We'll reach out within one business day to discuss a referral partnership tailored to your practice.